ArticleNeurology. Clinical practice2021
Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology.
Open access · greenAbstract read
In one paragraph
Article in Neurology. Clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- The role of neuroimmunology subspecialty in disease management of patients with neuromyelitis optica spectrum disorder.Orphanet journal of rare diseases · 2026Article
- Curriculum Innovations: Virtual Didactics as a Tool for Harmonizing Education About Rare Topics in Neuroimmunology.Neurology. Education · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 1 institution in 1 country.
Le H HuaCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.ORCID 0000-0002-0535-3978
Ahmed Z ObeidatCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Lilyana AmezcuaCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Jeffrey A CohenCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Kathleen CostelloCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Jeffrey DunnCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Jeffrey M GelfandCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Myla D GoldmanCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.ORCID 0000-0002-5675-945X
Sarah HopkinsCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Douglas JefferyCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Stephen KriegerCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Scott D NewsomeCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Suma ShahCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Nancy L SicotteCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Vijayshree YadavCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
Erin E LongbrakeCleveland Clinic Lou Ruvo Center for Brain Health (LHH), Las Vegas, NV; Department of Neurology (AZO), Medical College of Wisconsin, Milwaukee; Keck School of Medicine at University of Southern California (LA), Los Angeles; Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research (JAC), OH; National Multiple Sclerosis Society (KC), New York, NY; Department of Neurology (JD), Stanford University School of Medicine, CA; Department of Neurology (JMG), University of California, San Francisco; Virginia Commonwealth University (MDG), Richmond; Children's Hospital of Philadelphia (SH), University of Pennsylvania Perelman School of Medicine; Piedmont Healthcare (DJ), Mooresville, NC; Corinne Goldsmith Dickinson Center for Multiple Sclerosis (SK), Icahn School of Medicine at Mount Sinai, New York, NY; Johns Hopkins School of Medicine (SDN), Baltimore, MD; Duke University School of Medicine (SS), Durham, NC; Department of Neurology (NLS), Cedars-Sinai Medical Center, Los Angeles, CA; Oregon Health and Science University (VY), Portland VA Medical Center, Portland; Veterans Affairs Multiple Sclerosis Centers of Excellence (VY); and Yale School of Medicine (EEL), Yale University, New Haven, CT.
National Multiple Sclerosis Society · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
Management of multiple sclerosis and neuroimmunologic disorders has become increasingly complex because of the expanding number of recognized neuroimmune disorders, increased number of therapeutic options, and multidisciplinary care management needs of people with multiple sclerosis and neuroimmunologic disorders. More subspecialists are needed to optimize care of these patients, and many fellowship programs have been created or expanded to increase the subspecialty workforce. Consequently, defining the scope and standardizing fellowship training is essential to ensure that trainees receive high-quality training. A workgroup was created to develop a consensus fellowship curriculum to serve as a resource for all current and future training programs. This curriculum may also serve as a basis for future accreditation efforts.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.